The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
2.080
+0.040 (1.96%)
At close: Aug 29, 2025, 4:00 PM
2.075
-0.005 (-0.24%)
After-hours: Aug 29, 2025, 4:20 PM EDT
The Beauty Health Company Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for The Beauty Health Company stock has a target of 1.25, which predicts a -39.90% decrease from the current stock price of 2.08.
Price Target: $1.25 (-39.90%)
Analyst Consensus: Hold
* Price targets were last updated on May 5, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for The Beauty Health Company is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.5 → $1.25 | Hold | Maintains | $1.5 → $1.25 | -39.90% | May 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.75 → $1.5 | Hold | Maintains | $1.75 → $1.5 | -27.88% | Mar 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.25 → $1.75 | Hold | Maintains | $1.25 → $1.75 | -15.87% | Nov 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -39.90% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Sell Reiterates $1.5 → $1 | Sell | Reiterates | $1.5 → $1 | -51.92% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
299.19M
from 334.29M
Decreased by -10.50%
Revenue Next Year
317.30M
from 299.19M
Increased by 6.05%
EPS This Year
-0.16
from -0.36
EPS Next Year
-0.11
from -0.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 314.3M | 349.6M | ||
| Avg | 299.2M | 317.3M | ||
| Low | 284.2M | 296.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -6.0% | 16.9% | ||
| Avg | -10.5% | 6.1% | ||
| Low | -15.0% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.09 | -0.03 | ||
| Avg | -0.16 | -0.11 | ||
| Low | -0.20 | -0.23 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.